Alector (ALEC) Share-based Compensation Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alector (ALEC) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 109.14% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 5.27% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 12.91% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 6.35% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 17.49% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 4.55% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.68% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 30.98% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -40.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.29% |
| Mar 31, 2026 | -38.76% |
| Dec 31, 2025 | -23.84% |
| Sep 30, 2025 | -21.40% |
| Jun 30, 2025 | -19.90% |
| Mar 31, 2025 | -12.64% |
| Dec 31, 2024 | -7.02% |
| Sep 30, 2024 | -6.81% |
| Jun 30, 2024 | -6.70% |
| Mar 31, 2024 | -6.56% |
| Dec 31, 2023 | 9.04% |
| Sep 30, 2023 | 0.09% |
| Jun 30, 2023 | 20.85% |
| Mar 31, 2023 | 11.83% |
| Dec 31, 2022 | 27.91% |
| Sep 30, 2022 | 24.02% |
| Jun 30, 2022 | 34.35% |
| Mar 31, 2022 | 31.75% |
| Dec 31, 2021 | 68.41% |
| Sep 30, 2021 | 77.99% |